ATE446096T1 - Topische präparate zur behandlung von dermatitis - Google Patents

Topische präparate zur behandlung von dermatitis

Info

Publication number
ATE446096T1
ATE446096T1 AT02788607T AT02788607T ATE446096T1 AT E446096 T1 ATE446096 T1 AT E446096T1 AT 02788607 T AT02788607 T AT 02788607T AT 02788607 T AT02788607 T AT 02788607T AT E446096 T1 ATE446096 T1 AT E446096T1
Authority
AT
Austria
Prior art keywords
weight
dermatitis
medicine
treatment
cyclodextrin
Prior art date
Application number
AT02788607T
Other languages
English (en)
Inventor
Hajime Yamada
Akira Yamada
Original Assignee
Cac Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cac Corp filed Critical Cac Corp
Application granted granted Critical
Publication of ATE446096T1 publication Critical patent/ATE446096T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
AT02788607T 2002-06-03 2002-11-12 Topische präparate zur behandlung von dermatitis ATE446096T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002161000 2002-06-03
PCT/JP2002/011747 WO2003101460A1 (fr) 2002-06-03 2002-11-12 Preparations a usage externe pour le traitement de la dermatite

Publications (1)

Publication Number Publication Date
ATE446096T1 true ATE446096T1 (de) 2009-11-15

Family

ID=29706567

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02788607T ATE446096T1 (de) 2002-06-03 2002-11-12 Topische präparate zur behandlung von dermatitis

Country Status (14)

Country Link
US (1) US7897161B2 (de)
EP (1) EP1512404B1 (de)
JP (1) JP3820577B2 (de)
KR (1) KR100647857B1 (de)
CN (1) CN1219520C (de)
AT (1) ATE446096T1 (de)
AU (1) AU2002355005B2 (de)
CA (1) CA2488011C (de)
DE (1) DE60234132D1 (de)
DK (1) DK1512404T3 (de)
ES (1) ES2356370T3 (de)
HK (1) HK1060981A1 (de)
TW (1) TWI278318B (de)
WO (1) WO2003101460A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005053841A (ja) * 2003-08-05 2005-03-03 Kyouto Biomedical Science:Kk 皮膚外用剤
ES2522895T3 (es) 2005-03-03 2014-11-19 Alfa Wassermann S.P.A. Nuevas formas polimorfas de rifaximina, procedimientos para su producción y uso de las mismas en preparados medicinales
MY142987A (en) * 2005-06-08 2011-02-14 Hayashibara Biochem Lab Solution for tissue adhesion prevention and method for tissue adhesion prevention
EP2184997A4 (de) * 2007-07-31 2010-11-03 Univ New York Diagnose- und behandlungsverfahren für die charakterisierung von bakteriellen mikroorganismen bei hautkrankheiten
US7854936B2 (en) * 2008-01-14 2010-12-21 Active Organics, Inc. Anti-inflammatory hydrolysate of C. versicolor
JP5456802B2 (ja) * 2012-01-23 2014-04-02 株式会社Ｃａｃ 細胞遊走促進剤及び創傷治療用の経皮吸収剤
ITMI20122002A1 (it) * 2012-11-26 2014-05-27 Farmacologico Milanese Srl Lab Preparazioni farmaceutiche liquide stabilizzate
CA2931862C (en) 2013-11-08 2024-01-23 Carlos Filipe Method of stabilizing molecules without refrigeration using water soluble polymers and applications thereof in performing chemical reactions
CN106413759B (zh) * 2014-03-28 2022-02-22 列日大学 用于治疗和预防肺部炎症的包含环糊精和布地奈德衍生物的组合物
RU2709464C2 (ru) * 2015-09-29 2019-12-18 Кимберли-Кларк Ворлдвайд, Инк. Синергическая композиция для сохранения здорового баланса микрофлоры
KR102071614B1 (ko) 2019-04-30 2020-01-30 김민청 6-디아조-5-옥소-l-노르루신을 포함하는 염증성 피부 질환 치료용 약제학적 조성물

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5799M (de) 1966-03-22 1968-03-25
US3859436A (en) 1968-10-02 1975-01-07 Kolmar Laboratories Sugar composition for topical application
US3777597A (en) 1970-04-29 1973-12-11 Pharmachem Corp Method of shaving employing an aqueous solution of dextran
US5547997A (en) * 1991-10-01 1996-08-20 Chemisches Laboratorium Dr. Kurt Richter Gmbh Plant-derived cosmetic composition and method of treatment of skin
GB9211736D0 (en) * 1992-06-03 1992-07-15 Univ Cardiff Allergic treatment
FR2719772B1 (fr) * 1994-05-11 1996-08-02 Goemar Lab Sa Composition cosmétique ou pharmaceutique, notamment dermatologique contenant de la laminarine ou des oligosaccharides dérivés de laminarine.
JP2920611B2 (ja) 1995-12-11 1999-07-19 株式会社シーエーシー 皮膚炎の治療外用剤
JPH1025240A (ja) * 1996-04-09 1998-01-27 Dokutaazu Kosumeteikusu:Kk 浴用剤
JPH09315987A (ja) 1996-05-24 1997-12-09 Kureha Chem Ind Co Ltd 泡盛の抗アレルギー有効成分としての利用
DE19710368A1 (de) * 1997-03-13 1998-09-17 Henkel Kgaa Verwendung von wasserlöslichen beta-Glucanen als Wirkstoffe zur Herstellung von therapeutischen Mitteln zur Hautbehandlung
JPH11180813A (ja) * 1997-12-19 1999-07-06 Ichimaru Pharcos Co Ltd 海藻抽出物含有抗菌・防腐剤
AU3657100A (en) * 1999-03-12 2000-10-04 Biotec Asa Use of water-soluble beta-(1,3) glucans as agents for producing therapeutic skintreatment agents
US20030130248A1 (en) * 2000-05-31 2003-07-10 Mozzone Keith C. Topical anti-inflammatory compositions
JP2002114670A (ja) * 2000-10-02 2002-04-16 Noevir Co Ltd 抗菌性皮膚外用剤
JP2002060314A (ja) 2001-09-18 2002-02-26 Hakuto Co Ltd 皮膚外用剤

Also Published As

Publication number Publication date
WO2003101460A1 (fr) 2003-12-11
DE60234132D1 (de) 2009-12-03
JPWO2003101460A1 (ja) 2005-09-29
AU2002355005A1 (en) 2003-12-19
CA2488011C (en) 2008-02-12
DK1512404T3 (da) 2010-01-04
CA2488011A1 (en) 2003-12-11
US20050175640A1 (en) 2005-08-11
KR20050016479A (ko) 2005-02-21
US7897161B2 (en) 2011-03-01
CN1219520C (zh) 2005-09-21
TWI278318B (en) 2007-04-11
KR100647857B1 (ko) 2006-11-23
AU2002355005B2 (en) 2006-04-13
EP1512404A4 (de) 2006-04-12
HK1060981A1 (en) 2004-09-03
EP1512404B1 (de) 2009-10-21
EP1512404A1 (de) 2005-03-09
CN1466952A (zh) 2004-01-14
TW200307552A (en) 2003-12-16
ES2356370T3 (es) 2011-04-07
JP3820577B2 (ja) 2006-09-13

Similar Documents

Publication Publication Date Title
Kieliszek et al. Selenium supplementation in the prevention of coronavirus infections (COVID-19)
ATE446096T1 (de) Topische präparate zur behandlung von dermatitis
Martin Silicon: the health benefits of a metalloid
BR0309890A (pt) Composição farmacêutica contendo plasma sanguìneo, ou soro sanguìneo utilizada no tratamento de lesões, bem como seu método e processo de aplicação
NO20072895L (no) Topiske sammensetninger inneholdende myrica gale olje
CA2470492A1 (en) Aqueous compositions containing metronidazole
WO2004093722A3 (en) Topical treatment of dermatological disorders associated with reactive or dilated blood vessels
KR0181763B1 (ko) 피부염의 치료외용제
ATE444058T1 (de) Kosmetische zusammensetzung mit monosacchariden oder polysacchariden, anwendungen und behandlungsverfahren
Bakker et al. Evaluation of 7.5 years of surviving sepsis campaign guidelines
ATE228854T1 (de) Immunoglobuline der g-klasse zur lokalen behandlung von hautentzündungen
ATE206052T1 (de) Verwendung von sphingosin-1-phosphat, sphingosin- 1-phosphat-derivaten und/oder deren gemische zur behandlung von entzündlichen hautkrankheiten
CN106727664A (zh) 羧甲基壳聚糖在制备或筛选用于治疗皮肤瘙痒的产品中的用途
JP3890563B2 (ja) パーマネントウェーブ剤
BR0016426A (pt) Método para melhorar a produção de frutos das plantas
Gojda et al. Study of the relevance of development hand sanitizer
ATE282404T1 (de) Verwendung von biguanid und pyrimidin-derivaten zur herstellung topischer hautpflegezubereitungen
CN105106780B (zh) 一种治疗皮肤性疾病的中药擦剂
Poposka et al. P1495ECG parameters as predictors of response to cardiac resynchronization therapy
WO2003070185A3 (en) Method for treating cellulite
Alebiosu et al. A report of clinical trial conducted in Toto ointment and soap
EP1853286A2 (de) Zusammensetzung zur behandlung von hauterkrankungen
Gaballah et al. Catheter-directed and mechanical thrombolysis for management of lower extremity iliofemoral deep venous thrombosis: a single pediatric institutional experience
HARSAN et al. The Effect of Dimethyltin Phenylarsonate PhAsO3SnMe2 on the Roots, Shoots and Rhizogenesys of Chrysanthemum in Vitro
UA39025A (uk) Фотосенсибілізатор для лікування захворювань шкіри

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1512404

Country of ref document: EP